Cite Filings / SOPH / 0001178913-26-005168

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

SOPHiA GENETICS SA Filed 2026-11-12 Acc 0001178913-26-005168

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-11-12 4 Director sold 6,250 shares at $7.76 ($48,477)
2026-11-12 4 Executive Chairman sold 8,500 shares at $7.76 ($65,948)
2026-11-12 4 Chief Legal Officer sold 1,411 shares at $7.44 ($10,491)
2026-11-12 SCHEDULE 13D/A Beneficial Ownership Report
2026-11-09 144 Sale of Securities
2026-11-09 4 Chief Financial Officer bought 20,000 shares at $7.06 ($141,200)
2026-11-09 4 Chief Executive Officer bought 20,000 shares at $6.86 ($137,188)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…